INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 87 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $39,000 | +56.0% | 8,506 | +16.7% | 0.00% | – |
| Q4 2018 | $25,000 | -65.8% | 7,290 | +0.6% | 0.00% | -100.0% |
| Q3 2018 | $73,000 | +265.0% | 7,248 | +122.5% | 0.00% | – |
| Q2 2018 | $20,000 | 0.0% | 3,257 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | -75.6% | 3,257 | -61.7% | 0.00% | -100.0% |
| Q4 2017 | $82,000 | +331.6% | 8,512 | +311.6% | 0.00% | – |
| Q3 2017 | $19,000 | 0.0% | 2,068 | +34.7% | 0.00% | – |
| Q2 2017 | $19,000 | +11.8% | 1,535 | -0.1% | 0.00% | – |
| Q1 2017 | $17,000 | +325.0% | 1,536 | +208.4% | 0.00% | – |
| Q4 2016 | $4,000 | -69.2% | 498 | -57.5% | 0.00% | – |
| Q3 2016 | $13,000 | -60.6% | 1,173 | -51.8% | 0.00% | -100.0% |
| Q2 2016 | $33,000 | -13.2% | 2,435 | +7.3% | 0.00% | 0.0% |
| Q1 2016 | $38,000 | -24.0% | 2,270 | +28.2% | 0.00% | 0.0% |
| Q4 2015 | $50,000 | -66.7% | 1,770 | -66.6% | 0.00% | -66.7% |
| Q3 2015 | $150,000 | +85.2% | 5,305 | +132.6% | 0.00% | +200.0% |
| Q2 2015 | $81,000 | +42.1% | 2,281 | +135.9% | 0.00% | 0.0% |
| Q1 2015 | $57,000 | +54.1% | 967 | +13.0% | 0.00% | 0.0% |
| Q4 2014 | $37,000 | – | 856 | +7033.3% | 0.00% | – |
| Q3 2014 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 12 | -99.5% | 0.00% | -100.0% |
| Q1 2014 | $94,000 | +62.1% | 2,262 | +50.0% | 0.00% | +50.0% |
| Q4 2013 | $58,000 | – | 1,508 | +18750.0% | 0.00% | – |
| Q3 2013 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |